arrow
D

Dijiong Wu

浙江中医药大学
H指数:14
被引数:660

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cord blood transfusion added matched unrelated donor transplantation as a preferable choice for aplastic anaemia: a comparative study from a single centre

脐血输注增加了匹配无关供者移植作为再生障碍性贫血的优选方案:一项单中心比较研究

2026-03-160
OAAI
Efficacy and safety of hematopoietic stem cell transplantation vs. immunosuppressive therapy in patients with hepatitis-associated aplastic anemia: a systematic review and meta-analysis

造血干细胞移植与免疫抑制疗法在肝炎相关性再生障碍性贫血患者中的疗效与安全性:一项系统评价和荟萃分析

2025-12-310
OA
Haploidentical transplantation combined with mesenchymal stem cells co-infusion improves survival in severe aplastic anemia: a single-center retrospective study

haploidentical transplantation combined with mesenchymal stem cells co-infusion improves survival in severe aplastic anemia:一项单中心回顾性研究

2025-11-280
OAAI
Clinical characteristic of isolated thrombocytopenia in patients with bone marrow failure-related germline variants: a retrospective study from a single centre

孤立性血小板减少症在骨髓衰竭相关生殖细胞系变异患者中的临床特征:一项单中心回顾性研究

2025-06-260
OAAI
A nomogram for predicting T315I-free survival in chronic phase chronic myeloid leukemia patients: a multicenter retrospective study

预测慢性粒细胞白血病慢性期患者T315I-free生存率的列线图: 一项多中心回顾性研究

2025-02-180
OAAI
Existence and significance of anti-HLA-C autoantibodies to primary and persistent platelet transfusion refractoriness in patients with hematologic disorders: a retrospective study from a single centre

抗hla-c自身抗体对血液病患者初次和持续性血小板输注无效的存在及意义: 单中心回顾性研究

2024-12-280
OAAI
Myelofibrosis predicts deep molecular response 4.5 in chronic myeloid leukaemia patients initially treated with imatinib: An extensive, multicenter and retrospective study to develop a prognostic model
2024-11-220
OAAI
A Prognostic Model Guiding Treatment Switch for 5-Year Deep Molecular Response in Chronic Myeloid Leukemia Patients Receiving Initial Imatinib: An Extensive, Multi-Center, Retrospective Study

一个用于指导初始接受伊马替尼治疗的慢性髓系白血病患者在5年内实现深度分子缓解的治疗转换的预后模型:一项广泛的多中心回顾性研究

BLOOD
IF23.1
2024-11-050
PRE
Low-Dose Corticosteroids and Eltrombopag in the Treatment of Newly Diagnosed Adult Immune Thrombocytopenia: A Multicenter, Phase 2 Clinical Trial

小剂量皮质类固醇和Eltrombopag在初诊成人免疫性血小板减少症治疗中的应用:一项多中心、II期临床试验

BLOOD
IF23.1
2024-11-050
PRE